Kura Oncology Inc. logo

Kura Oncology Inc.

KURA | NASDAQ
Chart Builder DCF Calculator
$11.60
-$0.13 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$11.60
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:01 AM ET

Market Data

Market Cap
$1.04B
Enterprise Value
$535.21M
Beta
0.38
Average Volume
1.83M
Shares Outstanding (Diluted)
88.86M
Shares Change YoY
1.45%
Institutional Ownership
95.28%
Exchange
NASDAQ
ISIN
US50127T1097

Price Performance

Price Change 1M
-2.0%
Price Change 3M
11.8%
Price Change 6M
35.7%
Price Change YTD
12.2%
Price Change 1Y
43.4%
Price Change 3Y
30.9%
Price Change 5Y
-42.7%
1M CAGR (ann.)
26.4%
1Y CAGR (ann.)
45.0%
5Y CAGR (ann.)
-10.7%
All-Time CAGR
-2.2%

Valuation

PE Ratio
-3.44
Forward PE
N/A
PEG Ratio
0.09
Forward PEG
0.13
PS Ratio
13.33
Forward PS
4.90
PB Ratio
21.26
P/FCF Ratio
-8.77
P/Adj. FCF Ratio
-6.59
P/OCF Ratio
-9.21
EV/Sales
6.93
EV/EBIT
-1.81
EV/EBITDA
-1.83
EV/FCF
-4.56
Earnings Yield
-29.1%
FCF Yield
-11.4%
Adj. FCF Yield
-15.2%

Financial Health

Net Cash
$509.24M
Total Debt
$24.46M
Cash & Short-Term Investments
$519.03M
Total Assets
$587.79M
Current Ratio
4.73
Quick Ratio
4.71
Debt / Equity Ratio
0.50
Debt / EBITDA
-0.08
Debt / FCF
-0.21
OCF / Debt
-4.57
Interest Coverage
-224.01
Altman Z-Score
-2.60
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
94.7%
Operating Profit Margin
-411.9%
EBITDA Margin
-378.6%
Net Profit Margin
-384.3%
FCF Margin
-152.1%
Adj. FCF Margin
-202.5%
SBC / Revenue
50.4%
SBC Impact (per share)
-33.2%

Returns

Return on Assets
-50.5%
Return on Equity
-207.2%
Return on Invested Capital
-67.0%
Return on Capital Employed
-67.7%
Return on Tangible Assets
-50.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
72.2%
Revenue CAGR 5Y
74.1%
Revenue CAGR 10Y
47.1%
EPS CAGR 3Y
-21.8%
EPS CAGR 5Y
-12.4%
EPS CAGR 10Y
-7.7%
FCF CAGR 3Y
37.6%
FCF CAGR 5Y
29.8%
FCF CAGR 10Y
-3.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
17
EPS Growth Next 3Y
31.1%
Revenue Growth Next 3Y
85.5%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.84
EPS Growth Est (next Q)
-1.2%
Revenue Est (next Q)
$23.8M
Revenue Growth Est (next Q)
14.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$23.88
Price Target Upside
105.9%

Cash Flow

Operating Cash Flow
$-111.76M
Free Cash Flow
$-117.43M
Adj. Free Cash Flow
$-156.37M
FCF Per Share
-$1.32
OCF Per Share
-$1.26
OCF/S Ratio
-144.7%

Income Statement

Revenue
$77.23M
Gross Profit
$73.15M
Operating Income
$-318.09M
EBITDA
$-292.38M
Net Income
$-296.78M
EPS (Diluted)
-$3.37
Revenue / Employee
$297.02K
Profit / Employee
$-1.14M
Employees
260

© 2026 bestshares.com. All rights reserved.